Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00815009 · ClinicalTrials.gov registry record · NA

Evaluation of Diet and Exercise in Patients With Non-Alcoholic Fatty Liver Disease

A NA study of Fatty Liver, sponsored by San Antonio Military Medical Center.

Completed
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT00815009: Completed NA study of Fatty Liver, sponsored by San Antonio Military Medical Center.

NCT00815009 is a NA study of Fatty Liver that has completed, run by San Antonio Military Medical Center. The registered enrollment target is 56 participants, below the 208-participant average among 20 other Fatty Liver trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00815009, a NA study of Fatty Liver, has completed, sponsored by San Antonio Military Medical Center.

COMPLETED
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

Moderate exercise with a low fat and/or a moderate fat with low processed carbohydrate diet will have a greater effect on slowing disease progression and reversing hepatic steatosis and/or necro-inflammation in the liver of adult patients with NAFLD and NASH when compared to a regular healthy diet alone.

Conditions Studied

Interventions

  • BEHAVIORAL Mod Fat/Low Processed Carb Diet and Moderate Exercise
  • BEHAVIORAL Low Fat Diet and Moderate Exercise
  • BEHAVIORAL Moderate Exercise Only

Study Locations (1)

Texas

  • San Antonio Military Medical Center - Fort Sam Houston

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2008-10
Est. Completion 2010-12
Phase NA

What the finished NCT00815009 record still lists

NCT00815009 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 208-participant average among 20 other Fatty Liver trials with a reported enrollment target (73% lower).

The record links to 1 condition, with Fatty Liver appearing as the primary indexed condition, and to 3 interventions - of which Mod Fat/Low Processed Carb Diet and Moderate Exercise is the first listed.

NCT00815009 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT00815009 about?

NCT00815009 is a clinical study titled "Evaluation of Diet and Exercise in Patients With Non-Alcoholic Fatty Liver Disease". Moderate exercise with a low fat and/or a moderate fat with low processed carbohydrate diet will have a greater effect on slowing disease progression and reversing hepatic steatosis and/or necro-inflammation in the liver of adult patients with NAFLD and NASH when compared to a regular healthy diet a...

What is the current status of trial NCT00815009?

This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2008-10. Estimated completion is 2010-12.

What conditions does trial NCT00815009 study?

This clinical trial studies the following conditions: Fatty Liver.

What interventions are being tested in trial NCT00815009?

The interventions under investigation include: Mod Fat/Low Processed Carb Diet and Moderate Exercise (BEHAVIORAL), Low Fat Diet and Moderate Exercise (BEHAVIORAL), Moderate Exercise Only (BEHAVIORAL).

Who is sponsoring clinical trial NCT00815009?

This trial is sponsored by San Antonio Military Medical Center, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00815009 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fatty Liver

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00815009's enrollment target sits among peer trials

56 10th of 20 higher than 11 of 20 other Fatty Liver trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Fatty Liver trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02287428 · 56 participants · Phase 1

    Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

  • NCT02923011 · 56 participants · Phase 3

    Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

  • NCT02935283 · 56 participants

    Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

  • NCT03375866 · 56 participants · NA

    Effects of Mixed Nut Consumption on Satiety and Weight Management

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00815009, the US trial registry maintained by the National Library of Medicine. NCT00815009 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.